Here's Why We're Watching Athersys's (NASDAQ:ATHX) Cash Burn Situation

3 Biotech Stocks to Watch as the Race for a Coronavirus Vaccine Continues

On your mark, get set, go! The race is on to find an effective vaccine against COVID-19, the novel coronavirus that has spread to 471,000 people around the world and claimed more than 21,000 lives. According to the Coalition for Epidemic Preparedness Innovations (CEPI) chief executive Dr. Richard Hatchett, the current pandemic rivals the deadly 1918 Spanish flu, and thus finding a defense against the virus is of utmost importance. “There is a real sense of urgency...because the threat we are facing is unprecedented in the last 100 years in terms of its speed and potential severity,” he commented. As Hatchett estimates that the advancement of a vaccine at the necessary speed will cost $2 billion over the next 12-18 months, it’s no wonder Wall Street is watching the names taking on this formidable foe. Bearing this in mind, we turned to TipRanks’ database to get all the data on three...

U.S. Mortgage Rates Slip While Home Sales Head for Deep Freeze

(Bloomberg) -- U.S. mortgage rates fell for the first time in three weeks. But for would-be homebuyers frozen in fear of an economic meltdown, borrowing costs are no longer a prime concern.The average rate for a 30-year fixed loan was 3.5%, down from 3.65% last week, Freddie Mac said in a statement Thursday.Americans hunkering down in coronavirus quarantine are in no mood to shop for homes. Even if they can buy, many worry about how bad the coming recession will be, and how long it will last.In an early sign of slipping demand, a index of applications for home-purchase loans tumbled 15% last week to its lowest level since August, according to the Mortgage Bankers Association.Home sales are going to drop, no matter what mortgage rates do, said Matthew Speakman, an economist at Zillow. Eventually, the virus will pass and loan costs will start to matter again.“In the short term, the...